FDA NDC Directory · JSON-LD · Markdown

Teriparatide

NDC 0548-2311 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerAmphastar Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA213641
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsTERIPARATIDE (250 ug/mL)
Marketing started20251222
Package count1

External sources

Source: openFDA. Public-domain (CC0).